FMI
XERS icon

F/M Investments’s Xeris Biopharma Holdings XERS Stock Holding History

F/M Investments’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.2M Buy
+207,543
New +$1.38M 0.08% 151

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

F/M Investments's XERS Position: Q1 2026 in Review

F/M Investments opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 207,543 shares worth $1.2M. The stake represents 0.08% of the portfolio and ranks #151 among its holdings.

237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • F/M Investments held 207,543 shares of Xeris Biopharma Holdings worth $1.2M as of Q1 2026.
  • Xeris Biopharma Holdings was a new F/M Investments position in Q1 2026.
  • Xeris Biopharma Holdings made up 0.08% of F/M Investments's portfolio in Q1 2026, its #151 holding.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.